# Radiation Therapy in Treating Patients With Stage II Prostate Cancer

> **NCT00331773** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 1116 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Conventional 3D-CRT or IMRT
- **RADIATION:** Hypofractionated 3D-CRT or IMRT

## Key facts

- **NCT ID:** NCT00331773
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2015-07
- **Final completion:** 2022-12-22
- **Target enrollment:** 1116 (ACTUAL)
- **Last updated:** 2023-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331773, "Radiation Therapy in Treating Patients With Stage II Prostate Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00331773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*